Lan Kang

Lan Kang

Directeur/Membre du Conseil chez AVANTOR, INC.

Fortune : 640 558 $ au 30/06/2024

55 ans
Finance
Health Technology
Consumer Services

Profil

Lan Kang is currently the Chairman at Pramerica Fosun Life Insurance Co. Ltd., the Director at Ironshore, Inc., the Independent Director at Avantor, Inc., the Senior Managing Director at Shanghai Kangshiqiao Business Consulting Co. Ltd., and the Managing Director at C Bridge Value Creation Ltd.
Previously, Ms. Kang served as the Chairman of the Board at AmeriTrust Group, Inc., the Vice Chairman of the Board at Fidelidade Companhia de Seguros SA, the Executive Director & Chief Human Resources Officer at Fosun International Ltd., the Non-Executive Director at Shanghai Fosun Pharmaceutical (Group) Co., Ltd., the Director at Peak Reinsurance Co., Ltd., and the Non-Executive Director at Everest Medicines Ltd.
Ms. Kang also held positions at Fosun United Health Insurance Co. Ltd., Fosun Pharma Group Co. Ltd., I-MAB Biopharma Co., Ltd., I-Mab, McKinsey & Co., Inc., and Shanghai Fosun High Technology (Group) Co., Ltd.
Ms. Kang started their career as a Project Manager at Nanjing Jiangbei New Area Industrial Investment Group Co. Ltd.
and later worked as a Senior Client Partner at Korn.
Ms. Kang also served as a Senior Advisor at Shanghai Henlius Biotech, Inc. Ms. Kang received a graduate degree from Tulane University (Louisiana), an undergraduate degree from Zhejiang University, and an MBA from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/05/2024 30 215 ( 0,00% ) 640 558 $ 30/06/2024

Postes actifs de Lan Kang

SociétésPosteDébut
AVANTOR, INC. Directeur/Membre du Conseil 14/04/2021
Shanghai Kangshiqiao Business Consulting Co. Ltd. Private Equity Investor 01/12/2020
C Bridge Value Creation Ltd. Directeur Général -
Président 01/09/2017
Directeur/Membre du Conseil 01/01/2015
Tous les postes actifs de Lan Kang

Anciens postes connus de Lan Kang

SociétésPosteFin
I-MAB Directeur/Membre du Conseil 01/04/2024
EVEREST MEDICINES LIMITED Directeur/Membre du Conseil 12/01/2024
SHANGHAI HENLIUS BIOTECH, INC. Consultant / Advisor 01/03/2020
Président 01/12/2018
░░░░ ░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Lan Kang

Formation de Lan Kang

Zhejiang University Undergraduate Degree
Tulane University (Louisiana) Graduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Lan Kang

Relations

99

Relations au 1er degré

23

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées6
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

Health Technology

FOSUN INTERNATIONAL LIMITED

Finance

EVEREST MEDICINES LIMITED

Health Technology

AVANTOR, INC.

Process Industries

I-MAB

Health Technology

SHANGHAI HENLIUS BIOTECH, INC.

Health Technology

Entreprise privées14

Finance

Finance

Finance

Finance

Commercial Services

Nanjing Jiangbei New Area Industrial Investment Group Co. Ltd.

Finance

Finance

Commercial Services

C Bridge Value Creation Ltd.

Fosun Pharma Group Co. Ltd.

Health Services

Shanghai Kangshiqiao Business Consulting Co. Ltd.

Finance

Finance

Health Technology

Voir les connexions sociétés